Looking beyond natural sequences
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.
Founded by Tristan Bepler PhD ’20 and former MIT professor Tim Lu PhD ’07, OpenProtein.AI offers researchers open-source models and other tools for protein engineering.
Read MoreBy providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.
Read MoreDriven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Read MoreProfessor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
Read MoreThe MIT senior will pursue a master’s degree at Cambridge University in the U.K. this fall.
Read MoreA new approach can reveal the features AI models use to predict proteins that might make good drug or vaccine targets.
Read MoreThe team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
Read MoreA new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
Read MoreLaunched with a gift from the Biswas Family Foundation, the Biswas Postdoctoral Fellowship Program will support postdocs in health and life sciences.
Read More
You must be logged in to post a comment.